Literature DB >> 24025709

Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.

R Alroughani1, S F Ahmed, R Behbahani, R Khan, A Thussu, K J Alexander, A Ashkanani, V Nagarajan, J Al-Hashel.   

Abstract

BACKGROUND: Kuwait was considered as low to intermediate risk area for MS.
OBJECTIVES: To determine the prevalence and incidence rates of MS among Kuwaiti nationals based on 2011 population census.
METHODS: This cross-sectional study was conducted between October 2010 and April 2013 using the newly developed national MS registry in Kuwait. Patients with a diagnosis of MS according to 2010 revised McDonald criteria were identified. The crude, age- and sex-specific prevalence and incidence rates among Kuwaiti patients were calculated.
RESULTS: 1176 MS patients were identified of which 927 (78.8%) were Kuwaitis and 249 (21.2%) were expatriates. Among Kuwaiti patients, female to male ratio was 1.8:1 with a mean age of 35.40 ± 10.99 years. The prevalence rate of MS was 85.05 per 100,000 persons (95% CI: 82.80 - 87.04). There was a peak in prevalence among patients aged 30-39 years. The incidence of MS was 6.88 per 100,000 persons (95% CI 5.52-8.55). Between 2003 and 2011, the incidence increased 3.22 and 2.54 times in women and men respectively.
CONCLUSION: Kuwait is considered a high-risk area for MS. The significant increase in prevalence and incidence rates may represent a true increase despite the improvement in case ascertainment and case definition.

Entities:  

Keywords:  Epidemiology; Kuwait; incidence; multiple sclerosis; prevalence

Mesh:

Year:  2013        PMID: 24025709     DOI: 10.1177/1352458513504328

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  19 in total

1.  Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.

Authors:  Suhail N Al-Shammri; Magdy G Hanna; Arpita Chattopadhyay; Abayomi O Akanji
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

2.  High nationwide incidence of multiple sclerosis in Sweden.

Authors:  Cecilia Ahlgren; Anders Odén; Jan Lycke
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

3.  Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait.

Authors:  Saeed Akhtar; Raed Alroughani; Ahmad Al-Shammari; Jarrah Al-Abkal; Yasser Ayad
Journal:  BMC Neurol       Date:  2014-08-26       Impact factor: 2.474

4.  Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?

Authors:  Raed Alroughani; Saeed Akhtar; Samar Ahmed; Raed Behbehani; Jasem Al-Hashel
Journal:  PLoS One       Date:  2016-11-01       Impact factor: 3.240

5.  Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis.

Authors:  Ahmed N Albatineh; Raed Alroughani; Rabeah Al-Temaimi
Journal:  Int J MS Care       Date:  2020-01-13

6.  Real-world use of fingolimod in patients with relapsing remitting multiple sclerosis: a retrospective study using the national multiple sclerosis registry in Kuwait.

Authors:  Jasem Al-Hashel; Samar F Ahmed; Raed Behbehani; Raed Alroughani
Journal:  CNS Drugs       Date:  2014-09       Impact factor: 6.497

7.  Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.

Authors:  Abdullah Al-Asmi; Salim Al-Rawahi; Zahir Saif Al-Moqbali; Yahya Al-Farsi; Musthafa M Essa; May El-Bouri; Roopa P Koshy; Arunodaya R Gujjar; P C Jacob; Abeer Al-Hodar; Samir Al Adawi
Journal:  BMC Neurol       Date:  2015-08-05       Impact factor: 2.474

Review 8.  Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.

Authors:  Raed A Alroughani; Hany M Aref; Saeed A Bohlega; Maurice P Dahdaleh; Imed Feki; Mohammed A Al Jumah; Muhammad Z Al-Kawi; Salam F Koussa; Mohamad A Sahraian; Isa A Alsharoqi; Bassem I Yamout
Journal:  BMC Neurol       Date:  2014-02-12       Impact factor: 2.474

9.  Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait.

Authors:  S Lamdhade; A Ashkanani; R Alroughani
Journal:  ISRN Neurol       Date:  2014-01-22

Review 10.  Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits.

Authors:  Klaus Lauer
Journal:  Int J Mol Sci       Date:  2014-02-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.